Hyperhomocysteinemia in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

Mayo Clinic Proceedings

Volumn 76, Issue 12, 2001, Pages 1213-1218

  Flemming, Kelly D ^a   Nguyen, Tu T ^a   Abu Lebdeh, Haitham S ^a   Parisi, Joseph E ^a   Wiebers, David O ^a   Sicks, Jorean D ^a   Ofallon, W Michael ^a   Petty, George W ^a  

^a MAYO CLINIC   (United States)

Author keywords

CADASIL = cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; GOM = granular osmophilic material; TIA = transient ischemic attack

Indexed keywords

HOMOCYSTEINE; METHIONINE;

ADULT; AMINO ACID METABOLISM; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAIN DISEASE; BRAIN INFARCTION; CADASIL; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; LEUKOENCEPHALOPATHY; MALE; PATHOGENESIS; PROVOCATION TEST; TRANSIENT ISCHEMIC ATTACK;

EID: 0035211927     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.12.1213     Document Type: Article

References (56)

1. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients
2. CADASIL: Notch signaling defect or protein accumulation problem?
3. Autosomal dominant syndrome with strokelike episodes and leukoencephalopathy
4. The phenotypic spectrum of CADASIL: Clinical findings in 102 cases
5. CADASIL in a North American family: Clinical, pathologic, and radiologic findings
6. An Italian kindred with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
7. Patterns of MRI lesions in CADASIL
8. CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
9. Hyperhomocysteinemia and thrombosis: Acquired conditions
10. Relationship between homocysteine and thrombotic disease
11. The pilot Stroke Data Bank: Definition, design, and data
12. Homocysteine and cysteine: Determinants of plasma levels in middle-aged and elderly subjects
13. Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: The Hordaland Homocysteine Study
14. Hyperhomocysteinaemia in stroke: Prevalence, cause, and relationships to type of stroke and stroke risk factors
15. The frequency of a common mutation of the methionine synthase gene in the Australian population and its relation to smoking and coronary artery disease
16. Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism
17. Folate-mediated incorporation of ring-2-carbon of histidine into nucleic acids: Influence of thyroid hormone
18. Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen
19. Hormone replacement therapy and plasma homocysteine levels
20. Elevated plasma concentrations of homocysteine in antiepileptic drug treatment
21. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease prevention
22. Determinants of plasma homocysteine
23. Dietary and other determinants of vitamin B6 parameters
24. The clinical meaning of Rankin 'handicap' grades after stroke
25. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability
26. Radioassay of serum folate
27. 12 in blood: A simple method
28. Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: Initial results from the NHLBI Family Heart Study
29. Fasting or post-methionine load homocysteine: Which should be measured in relation to vascular risk?
30. Endothelial cell dysfunction in homocystinuria
31. Homocystinemia: Vascular injury and arterial thrombosis
32. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke
33. Moderate homocysteinemia - A possible risk factor for arteriosclerotic cerebrovascular disease
34. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease
35. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects
36. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease: Effects of pyridoxine and folic acid treatment
37. Hyperhomocysteinemia: An independent risk factor for vascular disease
38. Disordered methionine/homocysteine metabolism in premature vascular disease: Its occurrence, cofactor therapy, and enzymology
39. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men
40. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study
41. Homocyst(e)ine and risk of cerebral infarction in a biracial population: The Stroke Prevention in Young Women study
42. Plasma homocysteine as a risk factor for vascular disease: The European concerted action project
43. Homocysteine, hypertension and stroke
44. Homocysteine and risk of stroke
45. Hyperhomocysteinaemia: With reference to its neuroradiological aspects
46. Inherited disorders of cobalamin and folate transport and metabolism
47. Clinical aspects of cystathionine beta-synthase deficiency: How wide is the spectrum?
48. Notch3 mutations in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a mendelian condition causing stroke and vascular dementia
49. Notch signalling pathway and human diseases
50. Endothelial changes in muscle and skin biopsies in patients with CADASIL
51. Strategies for the treatment of cystathionine beta-synthase deficiency: The experience of the Willink Biochemical Genetics Unit over the past 30 years
52. Demyelination and decreased S-adenosylmethionine in 5,10-methylenetetrahydrofolate reductase deficiency
53. Preventing coronary heart disease: B vitamins and homocysteine
54. Homocysteine, folic acid, and cardiovascular disease risk
55. Plasma homocysteine in the acute and convalescent phases after stroke
56. Differential diagnosis of a vascular leukoencephalopathy within a CADASIL family: Use of skin biopsy electron microscopy study and direct genotypic screening